Skip to main content

Table 1 Assay of marketed formulations

From: A novel simultaneous high performance liquid chromatography-PDA method for the determination of Tenofovir AF, Darunavir, Emtricitabine and Cobicistat in bulk and its application to marketed formulation

Formulation

Tenofovir AF

Darunavir

Emtricitabine

Cobicistat

Amount taken (mg)

Amount obtained

(mg)

% Assay*

Amount taken (mg)

Amount obtained (mg)

% Assay*

Amount taken (mg)

Amount obtained

% Assay*

Amount taken

Amount obtained

% Assay*

Symtuza tablets (Tenofovir AF + Darunavir + Emtricitabine + Cobicistat)

10

9.921

99.21

800

798.42

99.80

200

199.62

99.81

150

149.76

99.84

  1. *Average of three replicates